A necropsy case of human T lymphotropic virus I (HTLV-I) associated myelopathy (HAM) in a 64 year old man with serological and genetical confirmation of HTLV-I infection is reported. The spinal cord, lung, and skin were mainly affected. Severe degeneration had occurred in the spinal cord, not only in the lateral columns but also in the anterior and posterior columns. Case report A 64 year old Japanese man, from southern Japan, had received blood transfusions at surgery for A-C bypass in 1985 when he was 57 years old. A few months after surgery, he noticed erythema on the chest and limbs. In 1990, muscular weakness of the lower extremities set in and bladder and rectal dysfunction developed. The weakness increased slowly but steadily and spread to the upper extremities, and he could not walk without a Zimmer frame. In June 1991, he was referred to the department of neurology of our hospital. On admission, neurological examinations disclosed spastic gait, weakness, and atrophy of the arm and leg muscles, and hyperreflexia in the extremities with bilateral Babinski's sign. Deep sensation, including position and vibration sense, and superficial sensation were decreased. The cranial nerves were intact. A computed tomogram of the brain was normal except for mild subdural effusion.
HTLV-I is the first isolate of human retroviruses and its aetiological role in adult T cell leukaemia (ATL) has been firmly established.' HTLV-I has also been reported to be implicated in the pathogenesis of certain types of chronic progressive myelopathy. The disease is prevalent in areas endemic for HTLV-I infection, such as Jamaica, Colombia, Martinique and the Seychelles, where it is known as tropical spastic paraparesis (TSP),2 and in the southern part of Japan as HTLV-I associated myelopathy (HAM) . 3 It is now agreed that TSP and HAM are the same disease. Moreover, an association between HTLV-I and bronchopneumonopathy has recently been suggested, although the precise mechanism is not clear. 45 As far as we know, this is the first necropsy case of HAM with pulmonary and cutaneous lesions.
Case report A 64 year old Japanese man, from southern Japan, had received blood transfusions at surgery for A-C bypass in 1985 when he was 57 years old. A few months after surgery, he noticed erythema on the chest and limbs. In 1990, muscular weakness of the lower extremities set in and bladder and rectal dysfunction developed. The weakness increased slowly but steadily and spread to the upper extremities, and he could not walk without a Zimmer frame. In June 1991, he was referred to the department of neurology of our hospital. On admission, neurological examinations disclosed spastic gait, weakness, and atrophy of the arm and leg muscles, and hyperreflexia in the extremities with bilateral Babinski's sign. Deep sensation, including position and vibration sense, and superficial sensation were decreased. The cranial nerves were intact. A computed tomogram of the brain was normal except for mild subdural effusion.
The peripheral blood leucocyte count was 13-6 x 103/ul) with 54 0% lymphocytes. Serological tests for syphilis and HIV-I yielded negative results. Antibodies to HTLV-I in the serum and CSF were positive at titres of more than 256x and 256x, respectively, by the particle agglutination test (Fuji Rebio). Proviral DNA of HTLV-I in peripheral mononuclear cells showed polyclonal integration by Southern blot analysis. A chest x-ray showed diffuse fine reticular shadows in both lung fields. Treatment with steroids initially improved spasticity and muscle power to some extent, but erythema had developed over the whole body. A biopsy specimen of the skin of the right forearm lesion showed dense and bandlike lymphoid cell infiltration in the upper dermis. These lymphoid cells showed mild atypia and epidermotropism but were not convoluted. Though HTLV-I associated lymphoma was strongly suspected, the integration of proviral DNA of HTLV-I in this lesion showed a polyclonal pattern by Southern blot analysis. The skin lesions were treated by painting with steroids.
In November of 1991, dyspnoea developed and in February 1992, emergency surgery for perforation of descending colon was performed. One month later, bleeding of the gastrointestinal tract set in and sclerotherapy was performed. In spite of supportive treatment his condition deteriorated, and the patient died of congestive heart failure in March, at the age of 64, two years after the onset of the disease.
Necropsy findings
The specimens were fixed in 10% formalin, and paraffin wax sections were stained with haematoxylin and eosin and by the method of Kliiver and Barrera. For immunohistochemical analysis, using the avidin-biotin complex method, preparations were made from 3 pum thick paraffin wax sections and the following monoclonal antibodies were used: MT1 and UCHL1 for T cells; L26 for B cells; and OPD4 for helper/inducer T cells.6 All antibodies were purchased from Dakopatts. The spinal cord was grossly atrophic, most obviously at the thoracic level. Microscopically, the lateral columns had degenerated in the lower thoracic cord, and symmetrical myelin and axon were lacking. Only a few inflammatory cells were observed in this lesion. On the other hand, in the middle and upper thoracic cord, the anterior and posterior (Goll's tract and the medial border of the bilateral Burdach's tract) columns had degenerated. These lesions contained lymphocytic perivascular cuffs in the white matter, where loss of axon and myelin along with infiltration of foamy macrophages and proliferation of capillaries were observed (fig 1) . The anterior spinal artery showed thickening of the media and periadventitial infiltration with lymphocytes (fig 2) . Almost all the perivascular and parenchymal lymphocytes in the spinal cord were positive for T cell markers (MT1, UCHL 1). About 15%-20% of these T cells were positive for OPD4. Figure 3 Lymphocytic infiltration in the penibronchus of the lung.
transfusion at A-C bypass operation, because none of his family so far examined has been positive for HTLV-I. Previous pathological findings in HAM have included almost symmetrical and severe degeneration of the spinal long tracts, accompanied by pronounced parenchymal exudation of lymphocytes and monocytes in the lateral columns and at the lower thoracic cord.7 In our case loss of myelin and axon were seen in the lower thoracic cord, but few inflammatory cells were present. On the other hand, the middle and upper thoracic cords presented perivascular cuffing and many foamy macrophages. In general, the older lesions were always in the lower thoracic cord, so the absence of inflammatory reactions in this lesion did not seem surprising. On the other hand, the lesions in the upper thoracic segments seemed to be relatively new. Interestingly, in addition to the typical clinical and pathological findings for HAM, our patient had cutaneous and pulmonary lesions. A biopsy specimen of erythema lesions showed dense and bandlike lymphoid cell infiltration with mild atypia and epidermotropism. From these observations, we could not exclude the possibility of HTLV-I-associated lymphoma, but Southern blot analysis using peripheral mononuclear cells and skin lesions showed polyclonal integration for HTLV-I proviral DNA.
On the other hand, the lung was infiltrated with lymphocytes with a predominance of OPD4 positive cells and vascular proliferation in the peribronchus. Recently pulmonary disease in a patient with HAM has been reported. 4 In this lesion a chest x-ray picture occasionally revealed micronodular infiltrates in both lower lung fields, and specimens obtained by transbronchial lung biopsy showed lympocytic infiltration in the alveolar and bronchial structures. These lymphocytes mainly consisted of T cells which did not resemble blast cells morphologically. Maruyama et al reported pulmonary disease not only in patients with HAM but also among healthy HTLV-I carriers without any other diseases.
They found that the HTLV-I antibody was positive in the bronchoalveolar lavage fluid (BAL).5 In our case, most of the peribronchial lymphocytes were positive for T cell markers (MT1, UCHL1) with a predominance of morphological normal OPD4 positive cells. These findings support the conclusion that our case was compatible with HTLV-I associated bronchopneumonopathy, although HTLV-I antibody in BAL was not examined.
This case confirms that HTLV-I causes multiorganic inflammatory disorders, although the definitive role of HTLV-I in the pathogenesis is still unknown. 
